884 related articles for article (PubMed ID: 33358970)
21. Congenital malformations among offspring of women with type 1 diabetes who use insulin pumps: a prospective cohort study.
Thorius IH; Husemoen LLN; Nordsborg RB; Alibegovic AC; Gall MA; Petersen J; Mathiesen ER
Diabetologia; 2023 May; 66(5):826-836. PubMed ID: 36640191
[TBL] [Abstract][Full Text] [Related]
22. Outcome of pregnancy in women with type 1 diabetes intensively treated with continuous subcutaneous insulin infusion or conventional therapy. A case-control study.
Giménez M; Conget I; Nicolau J; Pericot A; Levy I
Acta Diabetol; 2007 Mar; 44(1):34-7. PubMed ID: 17357884
[TBL] [Abstract][Full Text] [Related]
23. Comparative effectiveness of continuous subcutaneous insulin infusion using insulin analogs and multiple daily injections in pregnant women with diabetes mellitus: a systematic review and meta-analysis.
Ranasinghe PD; Maruthur NM; Nicholson WK; Yeh HC; Brown T; Suh Y; Wilson LM; Nannes EB; Berger Z; Bass EB; Golden SH
J Womens Health (Larchmt); 2015 Mar; 24(3):237-49. PubMed ID: 25713996
[TBL] [Abstract][Full Text] [Related]
24. Insulin pump therapy with and without continuous glucose monitoring in pregnant women with type 1 diabetes: a prospective observational Orchestra Foundation study in Poland.
Cypryk K; Wender-Ozegowska E; Cyganek K; Sieradzki J; Skoczylas K; Chen X; Cordero TL; Shin J; Cohen O
Acta Diabetol; 2023 Apr; 60(4):553-561. PubMed ID: 36653533
[TBL] [Abstract][Full Text] [Related]
25. Level of glycemic control and pregnancy outcome in type 1 diabetes: a comparison between multiple daily insulin injections and continuous subcutaneous insulin infusions.
Chen R; Ben-Haroush A; Weismann-Brenner A; Melamed N; Hod M; Yogev Y
Am J Obstet Gynecol; 2007 Oct; 197(4):404.e1-5. PubMed ID: 17904979
[TBL] [Abstract][Full Text] [Related]
26. Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.
Imbergamo MP; Amato MC; Sciortino G; Gambina M; Accidenti M; Criscimanna A; Giordano C; Galluzzo A
Clin Ther; 2008 Aug; 30(8):1476-84. PubMed ID: 18803989
[TBL] [Abstract][Full Text] [Related]
27. Continuous subcutaneous insulin infusion and multiple dose insulin injections in Type 1 diabetic pregnant women: a case-control study.
Volpe L; Pancani F; Aragona M; Lencioni C; Battini L; Ghio A; Resi V; Bertolotto A; Del Prato S; Di Cianni G
Gynecol Endocrinol; 2010 Mar; 26(3):193-6. PubMed ID: 19728190
[TBL] [Abstract][Full Text] [Related]
28. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis.
Keyu G; Jiaqi L; Liyin Z; Jianan Y; Li F; Zhiyi D; Qin Z; Xia L; Lin Y; Zhiguang Z
Front Public Health; 2022; 10():990281. PubMed ID: 36091534
[TBL] [Abstract][Full Text] [Related]
29. Long-term body weight trajectories and metabolic control in type 1 diabetes patients on insulin pump or multiple daily injections: A 10-year retrospective controlled study.
Alderisio A; Bozzetto L; Franco L; Riccardi G; Rivellese AA; Annuzzi G
Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1110-1117. PubMed ID: 31371264
[TBL] [Abstract][Full Text] [Related]
30. Multiple daily injections of insulin versus continuous subcutaneous insulin infusion for pregnant women with type 1 diabetes.
Wender-Ozegowska E; Zawiejska A; Ozegowska K; Wroblewska-Seniuk K; Iciek R; Mantaj U; Olejniczak D; Brazert J
Aust N Z J Obstet Gynaecol; 2013 Apr; 53(2):130-5. PubMed ID: 23316799
[TBL] [Abstract][Full Text] [Related]
31. MDI versus CSII in Chinese adults with type 1 diabetes in a real-world situation: based on propensity score matching method.
Yu J; Wang H; Zhu M; Xu J
Health Qual Life Outcomes; 2024 Jun; 22(1):47. PubMed ID: 38872219
[TBL] [Abstract][Full Text] [Related]
32. Comparison between continuous subcutaneous insulin infusion and multiple insulin injection therapy in type 1 diabetes mellitus: 18-month follow-up.
Hissa MN; Hissa AS; Bruin VM; Fredrickson LP
Endocr Pract; 2002; 8(6):411-6. PubMed ID: 15251830
[TBL] [Abstract][Full Text] [Related]
33. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes.
Hanaire-Broutin H; Melki V; Bessières-Lacombe S; Tauber JP
Diabetes Care; 2000 Sep; 23(9):1232-5. PubMed ID: 10977011
[TBL] [Abstract][Full Text] [Related]
34. HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment.
Scott ES; McGrath RT; Januszewski AS; Calandro D; Hardikar AA; O'Neal DN; Fulcher G; Jenkins AJ
BMJ Open; 2019 Dec; 9(12):e033059. PubMed ID: 31888933
[TBL] [Abstract][Full Text] [Related]
35. Diabetes control and pregnancy outcomes in women with type 1 diabetes treated during pregnancy with continuous subcutaneous insulin infusion or multiple daily insulin injections.
Cypryk K; Kosiński M; Kamińska P; Kozdraj T; Lewiński A
Pol Arch Med Wewn; 2008 Jun; 118(6):339-44. PubMed ID: 18619188
[TBL] [Abstract][Full Text] [Related]
36. Continuous subcutaneous insulin infusion therapy is associated with reduced retinopathy progression compared with multiple daily injections of insulin.
Reid LJ; Gibb FW; Colhoun H; Wild SH; Strachan MWJ; Madill K; Dhillon B; Forbes S
Diabetologia; 2021 Aug; 64(8):1725-1736. PubMed ID: 33966091
[TBL] [Abstract][Full Text] [Related]
37. Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes.
Alemzadeh R; Palma-Sisto P; Parton EA; Holzum MK
Diabetes Technol Ther; 2005 Aug; 7(4):587-96. PubMed ID: 16120030
[TBL] [Abstract][Full Text] [Related]
38. Comparison between a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) using continuous glucose monitoring in metabolically optimized type 1 diabetes patients: A randomized open-labelled parallel study.
Ruiz-de-Adana MS; Dominguez-Lopez ME; Gonzalez-Molero I; Machado A; Martin V; Cardona I; de-la-Higuera M; Tapia MJ; Soriguer F; Anarte MT; Rojo-Martínez G
Med Clin (Barc); 2016 Mar; 146(6):239-46. PubMed ID: 26656958
[TBL] [Abstract][Full Text] [Related]
39. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
Blair JC; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes DA; Gamble C;
BMJ; 2019 Apr; 365():l1226. PubMed ID: 30944112
[TBL] [Abstract][Full Text] [Related]
40. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
Pala L; Dicembrini I; Mannucci E
Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]